248 related articles for article (PubMed ID: 36056355)
1. The m
Zhang Y; Liu X; Wang Y; Lai S; Wang Z; Yang Y; Liu W; Wang H; Tang B
Mol Cancer; 2022 Sep; 21(1):174. PubMed ID: 36056355
[TBL] [Abstract][Full Text] [Related]
2. m
Tang B; Yang Y; Kang M; Wang Y; Wang Y; Bi Y; He S; Shimamoto F
Mol Cancer; 2020 Jan; 19(1):3. PubMed ID: 31906946
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA MACC1-AS1 promotes the stemness of nonsmall cell lung cancer cells through promoting UPF1-mediated destabilization of LATS1/2.
Wang X; Yu X; Wei W; Liu Y
Environ Toxicol; 2020 Sep; 35(9):998-1006. PubMed ID: 32401390
[TBL] [Abstract][Full Text] [Related]
4. LncRNA ZFPM2-AS1 promotes lung adenocarcinoma progression by interacting with UPF1 to destabilize ZFPM2.
Han S; Cao D; Sha J; Zhu X; Chen D
Mol Oncol; 2020 May; 14(5):1074-1088. PubMed ID: 31919993
[TBL] [Abstract][Full Text] [Related]
5. N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by activating the Wnt signaling pathway.
Lin C; Wang Y; Dong Y; Lai S; Wang L; Weng S; Zhang X
Biol Direct; 2022 Nov; 17(1):33. PubMed ID: 36397058
[TBL] [Abstract][Full Text] [Related]
6. LncRNA HIF1A-AS1 Promotes Gemcitabine Resistance of Pancreatic Cancer by Enhancing Glycolysis through Modulating the AKT/YB1/HIF1α Pathway.
Xu F; Huang M; Chen Q; Niu Y; Hu Y; Hu P; Chen D; He C; Huang K; Zeng Z; Tang J; Wang F; Zhao Y; Wang C; Zhao G
Cancer Res; 2021 Nov; 81(22):5678-5691. PubMed ID: 34593522
[TBL] [Abstract][Full Text] [Related]
7. ALKBH5-mediated m
He Y; Yue H; Cheng Y; Ding Z; Xu Z; Lv C; Wang Z; Wang J; Yin C; Hao H; Chen C
Cell Death Dis; 2021 Dec; 12(12):1121. PubMed ID: 34853296
[TBL] [Abstract][Full Text] [Related]
8. ALKBH5 Inhibits Pancreatic Cancer Motility by Decreasing Long Non-Coding RNA KCNK15-AS1 Methylation.
He Y; Hu H; Wang Y; Yuan H; Lu Z; Wu P; Liu D; Tian L; Yin J; Jiang K; Miao Y
Cell Physiol Biochem; 2018; 48(2):838-846. PubMed ID: 30032148
[TBL] [Abstract][Full Text] [Related]
9. A novel DDIT3 activator dehydroevodiamine effectively inhibits tumor growth and tumor cell stemness in pancreatic cancer.
Zhu SL; Qi M; Chen MT; Lin JP; Huang HF; Deng LJ; Zhou XW
Phytomedicine; 2024 Jun; 128():155377. PubMed ID: 38503154
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-induced long noncoding RNA NR2F1-AS1 maintains pancreatic cancer proliferation, migration, and invasion by activating the NR2F1/AKT/mTOR axis.
Liu Y; Chen S; Cai K; Zheng D; Zhu C; Li L; Wang F; He Z; Yu C; Sun C
Cell Death Dis; 2022 Mar; 13(3):232. PubMed ID: 35283481
[TBL] [Abstract][Full Text] [Related]
11. m
Jin D; Guo J; Wu Y; Yang L; Wang X; Du J; Dai J; Chen W; Gong K; Miao S; Li X; Sun H
Mol Cancer; 2020 Feb; 19(1):40. PubMed ID: 32106857
[TBL] [Abstract][Full Text] [Related]
12. lncRNA
Li N; Yang G; Luo L; Ling L; Wang X; Shi L; Lan J; Jia X; Zhang Q; Long Z; Liu J; Hu W; He Z; Liu H; Liu W; Zheng G
Clin Cancer Res; 2020 Apr; 26(7):1736-1748. PubMed ID: 31831555
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
14. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.
Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R
Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928
[TBL] [Abstract][Full Text] [Related]
15. Brucein D augments the chemosensitivity of gemcitabine in pancreatic cancer via inhibiting the Nrf2 pathway.
Zhang J; Xu HX; Cho WCS; Cheuk W; Li Y; Huang QH; Yang W; Xian YF; Lin ZX
J Exp Clin Cancer Res; 2022 Mar; 41(1):90. PubMed ID: 35272669
[TBL] [Abstract][Full Text] [Related]
16. IFN-γ affects pancreatic cancer properties by MACC1-AS1/MACC1 axis via AKT/mTOR signaling pathway.
Shi XY; Zhang XL; Shi QY; Qiu X; Wu XB; Zheng BL; Jiang HX; Qin SY
Clin Transl Oncol; 2022 Jun; 24(6):1073-1085. PubMed ID: 35037236
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA MACC1-AS1 promoted pancreatic carcinoma progression through activation of PAX8/NOTCH1 signaling pathway.
Qi C; Xiaofeng C; Dongen L; Liang Y; Liping X; Yue H; Jianshuai J
J Exp Clin Cancer Res; 2019 Aug; 38(1):344. PubMed ID: 31391063
[TBL] [Abstract][Full Text] [Related]
18. RREB1-induced upregulation of the lncRNA AGAP2-AS1 regulates the proliferation and migration of pancreatic cancer partly through suppressing ANKRD1 and ANGPTL4.
Hui B; Ji H; Xu Y; Wang J; Ma Z; Zhang C; Wang K; Zhou Y
Cell Death Dis; 2019 Feb; 10(3):207. PubMed ID: 30814490
[TBL] [Abstract][Full Text] [Related]
19. Long Non-coding Antisense RNA DDIT4-AS1 Regulates Meningitic Escherichia coli-Induced Neuroinflammation by Promoting DDIT4 mRNA Stability.
Yang B; Xu B; Yang R; Fu J; Li L; Huo D; Chen J; Yang X; Tan C; Chen H; Wang X
Mol Neurobiol; 2022 Mar; 59(3):1351-1365. PubMed ID: 34985734
[TBL] [Abstract][Full Text] [Related]
20. Targeting lncRNA DDIT4-AS1 Sensitizes Triple Negative Breast Cancer to Chemotherapy via Suppressing of Autophagy.
Jiang T; Zhu J; Jiang S; Chen Z; Xu P; Gong R; Zhong C; Cheng Y; Sun X; Yi W; Yang J; Zhou W; Cheng Y
Adv Sci (Weinh); 2023 Jun; 10(17):e2207257. PubMed ID: 37096846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
